Pioneering the next frontier in lifesaving diagnostic insights.
To make high-sensitivity biomarker testing available wherever care happens — delivering trusted results in minutes, so clinicians can act faster, health systems can operate more efficiently, and patients everywhere can achieve better outcomes.
Prolight’s strategy is to establish Psyros® as a leading and cost-effective point-of-care platform for high-sensitivity biomarker testing. The platform is initially being developed for areas with significant unmet medical needs, such as cardiovascular and neurological conditions, but has the potential to be used across a broad range of clinical applications.
By enabling rapid and reliable test results close to the patient within 10 minutes, Psyros has the potential to support more efficient clinical workflows, reduce healthcare costs and improve patient outcomes.
